JAK2 and myeloproliferative neoplasm: In the spring of 2005, almost simultaneously, five reports appeared describing a mutation in the gene coding for JAK2 also in this pseudo kinase JH2 domain, in patients with chronic myeloproliferative diseases [36-40].